107.522 articles found

[A guideline for the treatment of Parkinson's disease].

Miziuno Y, Okuma Y, Kikuchi S, Kuno S, Hashimoto T, Hasegawa K, Mano Y, Miwa H, Murata M, Yamamoto M, Yokochi F, Okiyama R, Kanazawa A, Shinpo K, Chuma T, Higashi T, Maruyama T, Mizuta E, Yamazaki S, Ad Hoc Committee on the Guidelines for the Treatment of Parkinson's Disease, Japanese Neurological Society.

Rinsho Shinkeigaku · 2002-05-01

PMID: 12708433

[The effect of shourong compound formula on levels of dopamine and its metabolites in brain of Parkinson's disease mice induced by reserpine].

Wang W, Zhao DZ, Sun XF, Gu SD.

Zhongguo Zhong Yao Za Zhi · 2002-05-01

PMID: 12774329

[Prevalence of CYPD6 mutations in sporadic Parkinson's disease: case-control study].

Guerrero D, García-Delgado M, Larumbe R, Vizmanos JL, Novo FJ, Viñes JJ.

An Sist Sanit Navar · 2002-05-01

DOI: 10.23938/assn.0795PMID: 12861292

Neuroprotection in Parkinson's disease: love story or mission impossible?

Linazasoro GJ.

Expert Rev Neurother · 2002-05-01

DOI: 10.1586/14737175.2.3.403PMID: 19810872

Possible role of nondopaminergic drugs on levodopa-induced dyskinesias in Parkinson's disease.

Jiménez-Jiménez FJ, de Toledo-Heras M.

Expert Rev Neurother · 2002-05-01

DOI: 10.1586/14737175.2.3.427PMID: 19810874

Voice analysis and videolaryngostroboscopy in patients with Parkinson's disease.

Yücetürk AV, Yilmaz H, Eğrilmez M, Karaca S.

Eur Arch Otorhinolaryngol · 2002-04-24

DOI: 10.1007/s00405-002-0462-1PMID: 12115074

A novel mutation (G217D) in the Presenilin 1 gene ( PSEN1) in a Japanese family: presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum.

Takao M, Ghetti B, Hayakawa I, Ikeda E, Fukuuchi Y, Miravalle L, Piccardo P, Murrell JR, Glazier BS, Koto A.

Acta Neuropathol · 2002-04-19

DOI: 10.1007/s00401-002-0536-6PMID: 12111359

Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment.

van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A.

Eur J Clin Pharmacol · 2002-04-05

DOI: 10.1007/s00228-002-0441-xPMID: 12012150

ADENOSINE A2A RECEPTOR ANTAGONISTS COMBINED WITH NEUROTROPHIC ACTIVITY COMPOUNDS IN THE TREATMENT OF PARKINSON'S DISEASE

PETERS Dan, RÏNN Lars Christian, NIELSEN Karin Sandager.

· 2002-04-04

ADENOSINE A2A RECEPTOR ANTAGONISTS COMBINED WITH NEUROTROPHIC ACTIVITY COMPOUNDS IN THE TREATMENT OF PARKINSON'S DISEASE

PETERS Dan c/o NeuroSearch A/S, RONN Lars Christian c/o NeuroSearch A/S, NIELSEN Karin Sandager c/o NeuroSearch A/S.

· 2002-04-04

Persistence of mild parkinsonism 4 months after liver transplantation in patients with preoperative minimal hepatic encephalopathy: a study on neuroradiological and blood manganese changes.

Lazeyras F, Spahr L, DuPasquier R, Delavelle J, Burkhard P, Hadengue A, Hochstrasser D, Mentha G, Giostra E, Terrier F, Vingerhoets F.

Transpl Int · 2002-04-04

DOI: 10.1007/s00147-002-0415-zPMID: 11976741

An MCASE approach to the search of a cure for Parkinson's Disease.

Klopman G, Sedykh A.

BMC Pharmacol · 2002-04-02

DOI: 10.1186/1471-2210-2-8PMID: 11926966